Dateline 10/3/2018 – Cicero, Illinois, United States: Pfizer announced the winner of the opportunity challenged city where it will be testing its new life extension drug, Extenda™. Extenda, which promises to eradicate between 2-5 years of cellular damage from sources such as cancer, heart disease and diabetes, will be widely available for free in Cicero, a suburb of Chicago. “We feel that of all the cities who applied to win the trial, Cicero was the most representative of the key ethnographic we were looking for” said a Pfizer spokesperson. Maude Adams, 53, a resident of Cicero, was overjoyed. “I knew that if I could just hold out a bit longer, a miracle would happen” Maude, who suffers from lung cancer from years of smoking and diabetes from obesity, couldn’t be happier. “I’ve always wanted a few more years with my family, and this will help” Cicero beat out 9 other cities for the Extenda trial, which will be distributed for free, as long as the recipients provide test results, blood samples, and complete symptoms reports.

About 6 years ago, I wrote a set of predictive stories about what life would be like 10 years out. Really interesting to go back to that time and see how much of that is on the way to actually happening: some of it – like 3d printers, are definitely moving along at a rapid clip. Others, not so much. I thought that you might find some of these interesting, so I’ll send them out in addition to my regular scheduled programming. Hope you enjoyed, and that it spurs some new thinking!


hellofuture develops insanely fun foresight & futurist programs, awesomely inspirational invention and innovation programs, and powerfully protective patent programs. Make a dent in the universe; build your next billion dollar business.
Like these posts? Get our twice weekly newletter, thinkfuture pulse:  
Chris Kalaboukis
Follow Me

Chris Kalaboukis

CEO / Co-Founder at hellofuture
Chris is a prolific inventor (60+ patents), exceptional innovator (headed internal banking, retail and technology innovation programs), experienced technologist, serial entrepreneur and futurist.
Chris Kalaboukis
Follow Me

Latest posts by Chris Kalaboukis (see all)